The deadline concerns Melzer et al. v. Johnson & Johnson Consumer Inc., No. 3:22-cv-03149, in the U.S. District Court for the District of New Jersey. Judge Michael A. Shipp granted preliminary approval on August 12, 2026. The approaching claim deadline is the current development; the settlement was proposed earlier. Preliminary-approval order
The lawsuit alleges that Johnson & Johnson Consumer Inc., now Kenvue Brands LLC, collected and used facial biometric information without the disclosures, written consent and public retention policy required by Illinois law. The company disputes those allegations. The settlement covers people who performed an assessment while in Illinois between December 9, 2019, and May 5, 2023, through a mobile or web application, including Neutrogena Skin360, NeoStrata Skin360 and other Skin360 collaborations. Court-authorized notice
Eligible class members can submit a claim online or mail a paper form postmarked by November 25. Valid claimants would receive equal shares of the money remaining after approved fees, expenses, administration costs and payments to the class representatives. No individual payment amount is guaranteed. Claim instructions and payment terms
The November 10 deadlines to opt out or object have passed. Class members who did not exclude themselves would be bound by the settlement’s release of covered claims if it becomes final—even if they submit no claim and receive no money. The final-approval hearing is scheduled for December 17, 2026; payments must await the settlement becoming effective. Notice explaining legal rights and deadlines
The settlement also requires confirmation that images obtained during covered assessments have been deleted. Subject to changes in applicable legal authority, the company must maintain a user notice, written-consent mechanism and policy governing retention and destruction of Skin360 information. These are settlement obligations, not a finding that the company violated the law. Settlement benefits and prospective obligations